Gene Therapy

ThermoGenesis Corp. Appoints William Osgood Chief Executive Officer and Director

Published in Medical Devices and Surgical Technology Week, August 19th, 2007

ThermoGenesis Corp. (NASDAQ:KOOL), a Company that develops and manufactures product platforms that enable the processing and cryopreservation of stem cells for regenerative medicine and processing of protein gels for surgical wound care, has appointed William Osgood, Ph.D., as Chief Executive Officer and a member of the Board of Directors effective July 30, 2007.

Osgood has served as the Company's President and Chief Operating Officer since April 2007 after joining ThermoGenesis in January 2007 as General Manager of Operations. Osgood succeeds Philip Coelho who has served as Chief Executive Officer since 1992 and will transition to the position of Chief Technology...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week

Source: Medical Devices and Surgical Technology Week (2007-08-19)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry